首页HBIO • NASDAQ
add
Harvard Bioscience, Inc.
昨日收盘价
$2.24
当日价格范围
$2.17 - $2.26
年度波幅
$1.99 - $5.56
市值
9679.97万 USD
平均交易量
16.06万
市盈率
-
股息率
-
主要交易所
NASDAQ
市场资讯
财务信息
损益表
收入
净收入
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
收入 | 2197.00万 | -13.38% |
经营支出 | 1446.00万 | -7.66% |
净收入 | -480.20万 | -287.57% |
净利润率 | -21.86 | -347.95% |
每股收益 | -0.02 | -300.00% |
息税折旧摊销前利润 | 12.00万 | -85.82% |
有效税率 | -6.92% | — |
资产负债表
总资产
负债总额
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
现金及短期投资 | 456.90万 | -14.44% |
总资产 | 1.31亿 | -6.08% |
负债总额 | 6591.70万 | 0.72% |
权益总额 | 6532.20万 | — |
发行在外的股份 | 4361.66万 | — |
市净率 | 1.49 | — |
资产回报率 | -3.26% | — |
资本回报率 | -3.85% | — |
现金流
现金净变动
| (USD) | 2024年9月info | 年同比变化 |
|---|---|---|
净收入 | -480.20万 | -287.57% |
来自运营的现金 | -84.20万 | -119.31% |
投资现金 | -111.10万 | -177.06% |
融资现金 | 210.40万 | 176.51% |
现金净变动 | 52.10万 | -48.72% |
自由现金流 | 58.66万 | -89.95% |
简介
Harvard Bioscience is a global developer, manufacturer and marketer of life sciences equipment to support research and drug discovery. It is traded on NASDAQ under the stock symbol HBIO.
Headquartered in Holliston, Massachusetts, United States, the company has 20 wholly owned subsidiaries. Brands include: AHN Biotechnologie, Biochrom, BioDrop, BTX, CMA, Coulbourn Instruments, Harvard Apparatus, HEKA, Hoefer, Hugo Sachs Elektronik, Multichannel Systems, Panlab, Scie-Plas, and Warner Instruments. Its CEO is James Green. The company has approximately 500 employees, with 300 of those in the USA, and five principal manufacturing facilities in New Brighton, Minnesota, Holliston, Massachusetts, Reutlingen, Germany, Barcelona, Spain, and March, Germany. Wikipedia
成立时间
1901
员工数量
404
